The switch between latency and replication of Epstein-Barr virus.
about
A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.Cooperative assembly of RNA polymerase II transcription complexes.Characterization of gammaherpesvirus 68 gene 50 transcriptionIdentification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirusMurine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latency-associated nuclear antigenChronic active Epstein-Barr virus disease in a case of persistent polyclonal B-cell lymphocytosis.Functional characterization of Kaposi's sarcoma-associated herpesvirus open reading frame K8 by bacterial artificial chromosome-based mutagenesis.Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the originORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus.Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas.Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy.Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latencyViral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined originThe latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanismActivation of the Epstein-Barr virus BMRF1 and BZLF1 promoters by ZEBRA in Saccharomyces cerevisiaeCharacterization of a glial cell line persistently infected with borna disease virus (BDV): influence of neurotrophic factors on BDV protein and RNA expressionActivation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli.Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.Primary tonsillar lymphomas according to the new World Health Organization classification: to report 87 cases and literature review and analysis.The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and rta antigens by flow cytometry.Expression of two related viral early genes in Epstein-Barr virus-associated tumors.Regulation of Epstein-Barr virus promoters in oral epithelial cells and lymphocytes.Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivationThe CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation.Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients.Comparing regions of the Epstein-Barr virus ZEBRA protein which function as transcriptional activating sequences in Saccharomyces cerevisiae and in B cells.Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia.Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.Rapid determination of Epstein-Barr virus latent or lytic infection in single human cells using in situ hybridization.The ZEBRA activation domain: modular organization and mechanism of action.Epstein-Barr virus and carcinomas.Lymphoblastoid cells transfected with c-myc: downregulation of EBV-lytic antigens and impaired response of autologous CD4+ T cells in vitro.
P2860
Q33559699-5A0C8A1C-E8A6-4E55-978B-BFAD3DF0101CQ33671418-6D1B1FEF-B566-4D02-BF7E-46B1F80168CBQ33798175-8A887D0A-ADCA-44CD-B1FA-30DDE32FB5A4Q33815257-B3F58FE9-1CCE-4868-8D76-015A86E38C5AQ34022999-145E13DD-CC22-4DB8-8925-8EBF68C65594Q34303017-C390ECA6-411D-49F4-87C2-FEF25AEC2CA6Q34741784-48356A72-2732-4428-AEC3-9D64E69A69EAQ34976942-E11C8C90-BD46-4270-822D-493EED05181AQ35101383-4DF57A8E-1C3B-4EC7-AAAF-C807C27B7621Q35235144-D9CEC5F5-832E-483B-AAB3-94435CF59A88Q35831803-E03313C6-6226-40C3-AD0A-EBA85AE61C74Q35874857-9E8CA4F3-3E1A-4F4E-A899-C54A41B6AF3DQ35977813-C731BFF7-75B7-4B6E-8BE3-089285C3FCC1Q36211665-6AAEE762-49BC-4D6D-90F2-798E44E4871AQ36298743-4F8224EF-554C-4BAB-949E-743B6177F75CQ36362069-B0541673-A0AD-4D08-9281-A1BC953AABEAQ36551194-D33BB0ED-FF89-416C-85C9-1ECBC5ED926AQ36622842-8FC9EDD0-31B7-4CDE-B551-D3ADCDD0AC2DQ36630074-4B054780-5B0C-4B30-AC39-1C38D5856386Q36637481-2A3BEBFA-A79C-4FAD-B394-74AFA38D9D1DQ36643580-A94B252C-B7EF-4756-931E-347AE9721157Q36648870-D0A85BCE-1159-437D-9E69-06DA7F661056Q36670819-30C8D563-4A82-4808-8F49-40264F746509Q37449248-64EBE8DA-6DE7-47E8-9F90-3A1D33C5741AQ37741847-93DDB960-F91E-43B3-ACAD-2E91BF59FCEBQ39444671-A16F7720-E5B7-48DC-A765-F23F019BCC05Q39507024-389151E1-EB26-4F0C-9C76-8DBA610E0F13Q39589909-EEB3C0AE-F030-4E80-8991-AA19E2EEF2D9Q39595288-3C83C65B-726A-445D-9F9A-E098C5674CC1Q39596534-5AF6E577-C29E-4032-93B8-7EE54A4AC775Q39604695-B5C2DF78-369A-48F7-A1A4-5CB8B65C1EDBQ39743627-74DCDDA7-DBAB-4599-9073-44E028C1EEBCQ39810535-902497D4-18AC-47AE-B03F-8E3E2F34ED32Q40048619-A0F52D00-AADD-4483-9061-558DF5A87B91Q40064626-417F1058-CFD8-47CF-932D-6679956052A6Q40066681-22623905-F4B9-4FB2-9F84-2728D1A3A910Q40491626-28B52766-8D88-41DC-B1A6-55A923F4A99BQ40656689-F1733D9D-DCFD-4CFD-A05F-01470FB4267AQ40853156-D9D7C455-9067-4E4C-8537-7B1510A649B1Q41145555-0794BC14-BD22-4E45-BFE4-BED090F4ED9E
P2860
The switch between latency and replication of Epstein-Barr virus.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The switch between latency and replication of Epstein-Barr virus.
@ast
The switch between latency and replication of Epstein-Barr virus.
@en
The switch between latency and replication of Epstein-Barr virus.
@nl
type
label
The switch between latency and replication of Epstein-Barr virus.
@ast
The switch between latency and replication of Epstein-Barr virus.
@en
The switch between latency and replication of Epstein-Barr virus.
@nl
prefLabel
The switch between latency and replication of Epstein-Barr virus.
@ast
The switch between latency and replication of Epstein-Barr virus.
@en
The switch between latency and replication of Epstein-Barr virus.
@nl
P356
P1476
The switch between latency and replication of Epstein-Barr virus.
@en
P2093
P304
P356
10.1093/INFDIS/161.5.833
P407
P577
1990-05-01T00:00:00Z